Atacicept in Multiple Sclerosis, Phase II

This study has been terminated.

( EMD Serono voluntarily decided to terminate this trial after observing increased MS disease activity in the atacicept treatment groups compared to placebo )

Study NCT00642902 Information provided by EMD Serono

First Received: March 21, 2008 Last Updated: September 25, 2009 History of Changes

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study has been terminated.
Estimated Study Completion Date:	December 2010
Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)